Sanuwave Health Inc. (NASDAQ:SNWV) Short Interest Down 45.8% in August

Sanuwave Health Inc. (NASDAQ:SNWV) was the target of a significant decrease in short interest during the month of August. As of August 14th, there was short interest totaling 304,527 shares, a decrease of 45.8% from the July 30th total of 561,489 shares. Based on an average daily volume of 109,529 shares, the days-to-cover ratio is currently 2.8 days. Approximately 4.1% of the company’s stock are short sold.

Sanuwave Health Stock Performance

Shares of SNWV traded up $0.02 during midday trading on Friday, reaching $4.68. The stock had a trading volume of 18,447 shares, compared to its average volume of 91,959. The firm has a 50 day simple moving average of $7.17 and a 200-day simple moving average of $14.72. Sanuwave Health has a one year low of $4.50 and a one year high of $42.75. The firm has a market cap of $40.25 million, a PE ratio of 19.50 and a beta of 1.48. The company has a current ratio of 1.28, a quick ratio of 0.89 and a debt-to-equity ratio of 4.87.

Sanuwave Health (NASDAQ:SNWV) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.05). Sanuwave Health had a return on equity of 1,728.10% and a net margin of 32.38%.The firm had revenue of $9.74 million for the quarter, compared to analyst estimates of $11.50 million.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered shares of Sanuwave Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Sanuwave Health has a consensus rating of “Moderate Buy” and a consensus target price of $51.00.

Institutional Trading of Sanuwave Health

Several institutional investors and hedge funds have recently bought and sold shares of SNWV. Bank of America Corp DE bought a new position in shares of Sanuwave Health during the 2nd quarter worth approximately $186,000. AWM Investment Company Inc. bought a new stake in Sanuwave Health in the 2nd quarter valued at $4,546,000. Solas Capital Management LLC bought a new stake in Sanuwave Health in the 2nd quarter valued at $6,110,000. BlackRock Inc. acquired a new stake in Sanuwave Health during the 2nd quarter valued at $1,599,000. Finally, Corient Private Wealth LLC bought a new position in Sanuwave Health during the fourth quarter worth $257,000. Institutional investors own 42.53% of the company’s stock.

About Sanuwave Health

Sanuwave Health, Inc is a medical technology company specializing in the development and commercialization of non-invasive acoustic wave therapies designed to stimulate tissue regeneration and accelerate healing. The company’s proprietary Extracorporeal Pulse Activated Technology (EPAT) delivers focused acoustic pressure waves to injured or chronic wound sites, activating the body’s natural repair mechanisms. Sanuwave’s primary therapeutic areas include advanced wound care for diabetic and venous ulcers, as well as orthopedic and musculoskeletal conditions.

The company’s lead product, the dermaPACE® system, holds clearance from the U.S.